Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Nitric Oxide and Andrographolide

Research Papers that Mention the Interaction

Andrographolide also stimulated endothelial nitric oxide synthase (eNOS) expression, NO release, and vasodilator-stimulated phosphoprotein (VASP) phosphorylation.
Journal of Molecular Medicine  •  2011  |  View Paper
The results demonstrated that andrographolide , isoandrographolide, 7-O-methylwogonin and skullcapflavone-I significantly inhibited LPS stimulated NO and PGE(2) release in J774A.1 macrophages.
International immunopharmacology  •  2011  |  View Paper
We found that andrographolide strongly reduced LPS-induced NO and iNOS expression.
Research in veterinary science  •  2020  |  View Paper
In addition, 5 mg/kg andrographolide treatment also decreased the expression of pro-inflammatory mediators and cytokines ( NO , COX-2, iNOS, IL-1β, IL-6 and TNF-α), NF-κB signaling (p-p65, p-IκBα) and NLRP3 inflammasome assembly (NLRP3, ASC and caspase-1) in the prefrontal cortex.
Toxicology and applied pharmacology  •  2019  |  View Paper
The results indicated that andrographolide clearly inhibited the production of NO and TNF-α in lipopolysaccharide-activated PMϕ in a dose-related manner.
Inflammopharmacology  •  2017  |  View Paper
In this study, we investigated the inhibitory effects of andrographolide on the induction of nitric oxide synthase (NOS) and cyclooxygenase-2 (COX-2) as well as their respective downstream products, NO and PGE2, in RAW264.7 cells treated with LPS.
Journal of ethnopharmacology  •  2011  |  View Paper
Serum NO level which was increased in B16F-10 melanoma injected control animals was also found to be significantly lowered by the administration of APE and ANDLE.
Taken together our results demonstrate that APE and ANDLE inhibit the tumor specific angiogenesis by regulating the production of various pro and antiangiogenic factors such as proinflammatory cytokine, nitric oxide , VEGF, IL-2 and TIMP-1.
International immunopharmacology  •  2007  |  View Paper
ANDRO significantly attenuated LPS-induced microglial activation and production of reactive oxygen species, tumor necrosis factor-α, nitric oxide , and prostaglandin E2.
Journal of Pharmacology and Experimental Therapeutics  •  2004  |  View Paper
As a whole, these data suggest that andrographolide inhibits NO synthesis in RAW 264.7 cells by reducing the expression of iNOS protein and the reduction could occur through two additional mechanisms: prevention of the de novo protein synthesis and decreasing the protein stability via a post‐transcriptional mechanism.
RAW 264.7 cells stimulated with …‐γ activated NO production; in this condition andrographolide (1–…) inhibited NO production in a dose‐dependent manner with an IC50 value of 17.4±1.1 μM. … also reduces the expression of iNOS protein level but without a significant effect on iNOS mRNA.
British journal of pharmacology  •  2000  |  View Paper
AG suppressed … of nitric oxide (NO) and prostaglandin E2 (PGE2), as well as the mRNA abundance of inducible NO synthase (iNOS), tumor necrosis factor-alpha (TNF-α), …)-2, and interferon-beta (IFN-β) in a dose-dependent manner in both lipopolysaccharide- (LPS-) activated RAW264.7 cells and peritoneal macrophages.
Evidence-based complementary and alternative medicine : eCAM  •  2013  |  View Paper